Browsing by Author "Rosenberg, Jonathan E."

Sort by: Order: Results:

  • Mullane, Stephanie A.; Werner, Lillian; Rosenberg, Jonathan E.; Signoretti, Sabina; Callea, Marcella; Choueiri, Toni K.; Freeman, Gordon J.; Bellmunt Molins, Joaquim, 1959- (Nature Publishing Group, 2016)
    Metastatic urothelial carcinoma (mUC) has a very high mutational rate and is associated with an APOBEC mutation signature. We examined the correlation of APOBEC expression with overall survival (OS) and PD-L1 expression ...
  • Moschini, Marco; Xylinas, Evanguelos; Zamboni, Stefania; Mattei, Agostino; Niegisch, Günter; Yu, Evan Y.; Bamias, Aristotle; Agarwal, Neeraj; Sridhar, Srikala S.; Sternberg, Cora N.; Vaishampayan, Ulka N.; Rosenberg, Jonathan E.; Bellmunt Molins, Joaquim, 1959-; Galsky, Matthew D.; Montorsi, Francesco; Necchi, Andrea; RISC Investigators (Elsevier, 2020)
    Purpose: SUDEP is the first cause of mortality related to epilepsy. However, in Spain there are no published cases or series from Epilepsy Monitoring Units that could expose the characteristics of SUDEP in our population. ...
  • Bellmunt Molins, Joaquim, 1959-; Lalani, Aly-Khan A.; Jacobus, Sussana; Mullane, Stephanie A.; Polacek, Laura; Takeda, David Y.; Harshman, Lauren C.; Wagle, Nikhil; Moreno, Irene; Lundgren, Kevin; Bossé, Dominick; Van Allen, Eliezer M.; Choueiri, Toni K.; Rosenberg, Jonathan E. (Nature Research, 2018)
    BACKGROUND: Metastatic urothelial carcinoma (mUC) is a genomically diverse disease with known alterations in the mTOR pathway and tyrosine kinases including FGFR. We investigated the efficacy and safety of combination ...
  • Bellmunt Molins, Joaquim, 1959-; Werner, Lillian; Bamias, Aristotle; Fay, André P.; Park, Rachel S.; Riester, Markus; Selvarajah, Shamini; Barletta, Justine A.; Berman, David M.; Muga, Silvia de; Salido, Marta; Gallardo, Enrique; Rojo, Federico; Guancial, Elizabeth A.; Bambury, Richard; Mullane, Stephanie A.; Choueiri, Toni K.; Loda, Massimo; Stack, Edward; Rosenberg, Jonathan E. (Wiley, 2015)
    We evaluated primary tumors from two cohorts, Spain (N = 111) and Greece (N = 102), for patients who were treated with platinum-based chemotherapy. Patients were tested for HER2 status (IHC score of 3+ or FISH ratio of ...
  • Bellmunt Molins, Joaquim, 1959-; Selvarajah, Shamini; Rodig, Scott; Salido Galeote, Marta; Muga, Silvia de; Costa, Irmgard; Bellosillo Paricio, Beatriz; Werner, Lillian; Mullane, Stephanie A.; Fay, André P.; O’Brien, Robert; Barretina, Jordi; Minoche, André E.; Signoretti, Sabina; Montagut Viladot, Clara; Himmelbauer, Heinz; Berman, David M.; Kantoff, Philip; Choueiri, Toni K.; Rosenberg, Jonathan E. (Public Library of Science (PLoS), 2014)
    Anaplastic lymphoma kinase (ALK) genomic alterations have emerged as a potent predictor of benefit from treatment with ALK inhibitors in several cancers. Currently, there is no information about ALK gene alterations in ...
  • Ramos, Jorge D.; Wingate, Jonathan T.; Gulati, Roman; Plimack, Elizabeth R.; Harshman, Lauren C.; Powles, Thomas; Crabb, Simon J.; Niegisch, Günter; Bellmunt Molins, Joaquim, 1959-; Ladoire, Sylvain; De Giorgi, Ugo; Hussain, Syed; Alva, Ajjai S.; Baniel, Jack; Agarwal, Neeraj; Rosenberg, Jonathan E.; Vaishampayan, Ulka N.; Galsky, Matthew D.; Yu, Evan Y. (Elsevier, 2018)
    BACKGROUND: Venous thromboembolism (VTE) is common in cancer patients, but there is limited data on patients with urothelial tract tumors (UTT). We previously identified several associative factors for increased VTE rates ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking